A Systematic Bibliometric Analysis of Cardiovascular Disease Risk in Obesity (2014-2024).

BACKGROUND

Obesity, as a global chronic disease, is causing an increasing risk of cardiovascular disease. This study used bibliometrics to synthesize and analyze publications related to obesity and cardiovascular risk from 2014 to 2024. It aimed to clarify the current status of research, predict future trends, and provide a scientific basis for prevention and treatment.

METHODS

In this study, we used bibliometrics online analysis platform, Citespace (version 6.3.R1, LLR algorithm) and VOSviewer (version 1.6.20) software to analyze the co-occurrence network analysis of publications related to cardiovascular risk of obesity in worldwide for countries, institutions, authors, and journals from January 2014 to September 2024, and keyword co-occurrence, clustering, and burst analysis were performed to reveal research trends and hotspots.

RESULTS

A total of 1492 articles related to cardiovascular risk in obesity were selected for this study, and in terms of the number of publications showed a steady increase over time. Based on keyword clustering analysis, the field can be summarized into two research themes: the field of the relationship between health indicators such as BMI, waist circumference, cardiovascular disease, and the field of metabolism and obesity-related issues. According to the keyword burst analysis, the keywords cholesterol, oxidative stress, non-alcoholic fatty liver disease, and ratio to height became prominent and will be the main research hotspots in the future.

CONCLUSION

In recent years, there has been a rapid increase in cardiovascular risk research in obese patients. This article reveals the remarkable progress and dynamic trends in this field, providing strong support for exploring new directions, as well as laying a data foundation for public health policy development and interdisciplinary collaboration. Future research should prioritize focusing on mechanism exploration and clinical application of novel drugs to promote health improvement.